Clinical Trials

Clinical Trials for MTG2

Filter list of Clinical Trials

TopicTrial name of investigational drugClinical Trial ID(s)StatusOrphaCodeLink
HypoparathyroidismA Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism - PCO 104 UG
  • NCT 04209179
  • Terminated
  • ORPHA181405
HypoparathyroidismA Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)
  • NCT03324880
  • ongoing
  • recruiting
  • ORPHA181405
HypoparathyroidismA Randomized, Double-Blind, Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PCO371 in Patients With Hypoparathyroidism
  • NCT04209179
  • Terminated
  • ORPHA181405
McCune- Albright SyndromeMCRN007 (D6992C00044) - An Open-Label, Non-Comparative Trial To Evaluate The Safety, Efficacy And Pharmacokinetics Of FASLODEX™ (Fulvestrant) In Girls With Progressive Precocious Puberty Associated With Mccune Albright Syndrome
  • NCT00278915
  • ongoing
  • ORPHA562
X-Linked HypophosphatemiaX linked Hypof (XLH) Registry for Patients With X-Linked Hypophosphatemia (XLH Registry)
  • NCT03193476
  • ongoing
  • ORPHA89936
X-linked hypophosphatemiaA phase 1/2, open-label, multicenter, non-randomized study to assess the safety, tolerability, pharmacokinetics and efficacy of Burosumab in pediatric patients from birth to less than 1 year of age with X-linked hypophosphatemia (XLH). BUR-CL207
  • NCT04188964
  • ongoing
  • ORPHA89936
TopicTrial name of investigational drugClinical Trial ID(s)StatusOrphaCodeLink

An overview of all Clinical Trials can be found here.